These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 35092883)
1. The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients. Sumiyoshi R; Tashiro H; Shirasaki R; Matsuo T; Yamamoto T; Matsumoto K; Ooi J; Shirafuji N Leuk Res; 2022 Feb; 113():106790. PubMed ID: 35092883 [TBL] [Abstract][Full Text] [Related]
2. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome. Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908 [TBL] [Abstract][Full Text] [Related]
3. Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes. Badar T; Patel KP; Thompson PA; DiNardo C; Takahashi K; Cabrero M; Borthakur G; Cortes J; Konopleva M; Kadia T; Bohannan Z; Pierce S; Jabbour EJ; Ravandi F; Daver N; Luthra R; Kantarjian H; Garcia-Manero G Leuk Res; 2015 Dec; 39(12):1367-74. PubMed ID: 26547258 [TBL] [Abstract][Full Text] [Related]
4. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667 [TBL] [Abstract][Full Text] [Related]
5. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in Sharawat SK; Raina V; Kumar L; Sharma A; Bakhshi R; Vishnubhatla S; Gupta R; Bakhshi S Indian J Med Res; 2016 May; 143(Supplement):S11-S16. PubMed ID: 27748272 [TBL] [Abstract][Full Text] [Related]
6. The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan. Lyu M; Liao H; Shuai X; Jin Y; Su J; Zheng Q Gene; 2020 Feb; 726():144195. PubMed ID: 31669649 [TBL] [Abstract][Full Text] [Related]
7. The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population. Xu F; Han R; Zhang J; Li Z; Wang J; Chu XL; Yu JQ; Wang C; Tao T; Shen HJ; Chen SN; Wu DP; Liu SB; Qiu QC; Xue SL Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):e107-e115. PubMed ID: 30555035 [TBL] [Abstract][Full Text] [Related]
8. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance]. Wang J; Wang T; Li S; Lin L; Gang Y Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of FLT3 ITD and D835 mutations in AML patients. Sheikhha MH; Awan A; Tobal K; Liu Yin JA Hematol J; 2003; 4(1):41-6. PubMed ID: 12692519 [TBL] [Abstract][Full Text] [Related]
10. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Gale RE; Green C; Allen C; Mead AJ; Burnett AK; Hills RK; Linch DC; Blood; 2008 Mar; 111(5):2776-84. PubMed ID: 17957027 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998 [TBL] [Abstract][Full Text] [Related]
12. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825 [TBL] [Abstract][Full Text] [Related]
13. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943 [TBL] [Abstract][Full Text] [Related]
14. FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia. Daver N; Strati P; Jabbour E; Kadia T; Luthra R; Wang S; Patel K; Ravandi F; Cortes J; Qin Dong X; Kantarjian H; Garcia-Manero G Am J Hematol; 2013 Jan; 88(1):56-9. PubMed ID: 23115106 [TBL] [Abstract][Full Text] [Related]
15. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia. How J; Sykes J; Gupta V; Yee KW; Schimmer AD; Schuh AC; Minden MD; Kamel-Reid S; Brandwein JM Cancer; 2012 Dec; 118(24):6110-7. PubMed ID: 22736495 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence of FLT3 internal tandem duplication in adult acute myelogenous leukemia]. Lee JN; Kim HR; Shin JH; Joo YD Korean J Lab Med; 2007 Aug; 27(4):237-43. PubMed ID: 18094582 [TBL] [Abstract][Full Text] [Related]
17. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia. Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077 [TBL] [Abstract][Full Text] [Related]
18. Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients. Wang L; Lin D; Zhang X; Chen S; Wang M; Wang J Leuk Res; 2005 Dec; 29(12):1393-8. PubMed ID: 15996732 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation. Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446 [TBL] [Abstract][Full Text] [Related]
20. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia. Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]